Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer

被引：0
|
作者：
Bashir Al Hussein Al Awamlh
Sam S. Chang
机构：
[1] Vanderbilt University Medical Center,Department of Urology
[2] A-1302 Medical Center Drive,undefined
[3] Vanderbilt Ingram Cancer Center,undefined
来源：
Current Oncology Reports | 2023年 / 25卷
关键词：
Non-muscle invasive bladder cancer; Intravesical chemotherapy; Carcinoma in situ of the bladder; BCG-unresponsive;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：83 / 91
页数：8
相关论文
共 50 条
  • [21] Immuno-oncological therapeutic options in high-risk non-muscle invasive bladder cancer
    Kramer, M. W.
    Gakis, G.
    UROLOGE, 2020, 59 (07): : 784 - 789
  • [22] URINARY EXTRACELLULAR VESICLE RNA BIOMARKERS FOR HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER
    Minami, Keita
    Osawa, Takahiro
    Murakami, Taku
    Harada, Hiroshi
    Harabayashi, Toru
    Takada, Norikata
    Kashiwagi, Akira
    Hirakawa, Kazushi
    Sato, Yasuyuki
    Matsumoto, Ryuji
    Kikuchi, Hiroshi
    Abe, Takashige
    Murai, Sachiyo
    Shinohara, Nobuo
    JOURNAL OF UROLOGY, 2020, 203 : E1008 - E1009
  • [23] Chromosomal Imbalance in the Progression of High-Risk Non-Muscle Invasive Bladder Cancer Editorial Comment
    Montie, James E.
    JOURNAL OF UROLOGY, 2010, 183 (03): : 938 - 939
  • [24] Non-muscle invasive bladder cancer risk stratification
    Isharwal, Sumit
    Konety, Badrinath
    INDIAN JOURNAL OF UROLOGY, 2015, 31 (04) : 289 - 296
  • [25] Predicting response to bacillus Calmette-Guerin in high-risk non-muscle invasive bladder cancer
    Soltani-Tehrani, Amir M.
    Kumar, Aman
    Pohar, Kamal S.
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (11) : 6489 - 6502
  • [26] Incidence, initial management and survival of high-risk non-muscle invasive bladder cancer in Northern France
    Saint, Fabien
    Pasquier, David
    Villers, Arnauld
    Massa, Jordan
    Colin, Pierre
    Vankemmel, Olivier
    Leroy, Xavier
    Bonnal, Jean-Louis
    Plouvier, Sandrine D.
    FRENCH JOURNAL OF UROLOGY, 2024, 34 (09):
  • [27] Intravesical chemohyperthermia with mitomycin c for intermediate- & high-risk non-muscle invasive bladder cancer
    Lai, B. C. H.
    Wen, Y. -C.
    Shih, H. -J.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 13 - 13
  • [28] Tumor mutation burden to predict progression in high-risk non-muscle invasive bladder cancer.
    Meeks, Joshua
    Carneiro, Benedito A.
    Pai, Sachin Gopalkrishn
    Oberlin, Daniel
    Rademaker, Alfred
    Fedorchak, Kyle
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [29] Role of Tissue Markers on Predicting the Prognosis of Intermediate and High-risk Non-muscle Invasive Bladder Cancer
    Abbasli, Abulfaz
    Citgez, Sinharib
    Demirdag, Cetin
    Gurbuz, Ahmet
    Erozenci, Ahmet
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2020, 19 (04): : 177 - 181
  • [30] Biomedical markers of response to intravesical BCG treatment in high-risk non-muscle invasive bladder cancer
    Jallad, S.
    Thomas, P.
    Newport, M.
    Kern, F.
    BRITISH JOURNAL OF SURGERY, 2014, 101 : 66 - 67
12345